vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.
TRANSCONTINENTAL REALTY INVESTORS INC is the larger business by last-quarter revenue ($12.1M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -234.3%, a 303.1% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 2.3%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 0.7%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.
FHTX vs TCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $9.2M | $12.1M |
| Net Profit | $-21.7M | $8.3M |
| Gross Margin | — | — |
| Operating Margin | -258.2% | -28.9% |
| Net Margin | -234.3% | 68.8% |
| Revenue YoY | 223.8% | 2.3% |
| Net Profit YoY | -11.1% | 7577.8% |
| EPS (diluted) | $-0.35 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $12.1M | ||
| Q3 25 | $8.2M | $12.8M | ||
| Q2 25 | $7.6M | $12.2M | ||
| Q1 25 | $6.0M | $12.0M | ||
| Q4 24 | $2.9M | $11.8M | ||
| Q3 24 | $7.8M | $11.6M | ||
| Q2 24 | $6.9M | $11.8M | ||
| Q1 24 | $5.0M | $11.9M |
| Q4 25 | $-21.7M | $8.3M | ||
| Q3 25 | $-15.8M | $724.0K | ||
| Q2 25 | $-17.9M | $169.0K | ||
| Q1 25 | $-18.8M | $4.6M | ||
| Q4 24 | $-19.5M | $108.0K | ||
| Q3 24 | $-19.1M | $1.7M | ||
| Q2 24 | $-23.0M | $1.5M | ||
| Q1 24 | $-25.0M | $2.5M |
| Q4 25 | -258.2% | -28.9% | ||
| Q3 25 | -226.9% | -10.9% | ||
| Q2 25 | -279.2% | -6.8% | ||
| Q1 25 | -385.0% | -5.3% | ||
| Q4 24 | -840.5% | -14.3% | ||
| Q3 24 | -305.5% | -14.4% | ||
| Q2 24 | -386.6% | -9.2% | ||
| Q1 24 | -558.3% | -11.2% |
| Q4 25 | -234.3% | 68.8% | ||
| Q3 25 | -194.4% | 5.6% | ||
| Q2 25 | -237.3% | 1.4% | ||
| Q1 25 | -316.4% | 38.5% | ||
| Q4 24 | -682.9% | 0.9% | ||
| Q3 24 | -244.9% | 14.7% | ||
| Q2 24 | -333.6% | 12.7% | ||
| Q1 24 | -495.4% | 21.4% |
| Q4 25 | $-0.35 | $0.97 | ||
| Q3 25 | $-0.25 | $0.08 | ||
| Q2 25 | $-0.28 | $0.02 | ||
| Q1 25 | $-0.30 | $0.53 | ||
| Q4 24 | $-0.23 | $0.01 | ||
| Q3 24 | $-0.31 | $0.20 | ||
| Q2 24 | $-0.45 | $0.17 | ||
| Q1 24 | $-0.59 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $89.0M |
| Total DebtLower is stronger | — | $210.8M |
| Stockholders' EquityBook value | $-108.5M | $846.7M |
| Total Assets | $198.1M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $89.0M | ||
| Q3 25 | $89.3M | $82.7M | ||
| Q2 25 | $72.6M | $73.5M | ||
| Q1 25 | $61.0M | $88.6M | ||
| Q4 24 | $55.5M | $99.7M | ||
| Q3 24 | $57.7M | $131.6M | ||
| Q2 24 | $138.9M | $127.5M | ||
| Q1 24 | $79.3M | $130.8M |
| Q4 25 | — | $210.8M | ||
| Q3 25 | — | $223.5M | ||
| Q2 25 | — | $212.4M | ||
| Q1 25 | — | $198.2M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $180.3M | ||
| Q2 24 | — | $177.4M | ||
| Q1 24 | — | $178.3M |
| Q4 25 | $-108.5M | $846.7M | ||
| Q3 25 | $-89.7M | $838.4M | ||
| Q2 25 | $-76.7M | $837.7M | ||
| Q1 25 | $-61.7M | $837.3M | ||
| Q4 24 | $-45.5M | $832.3M | ||
| Q3 24 | $-28.3M | $832.2M | ||
| Q2 24 | $-14.3M | $830.4M | ||
| Q1 24 | $-97.5M | $828.9M |
| Q4 25 | $198.1M | $1.1B | ||
| Q3 25 | $205.0M | $1.1B | ||
| Q2 25 | $226.2M | $1.1B | ||
| Q1 25 | $258.7M | $1.1B | ||
| Q4 24 | $284.0M | $1.1B | ||
| Q3 24 | $308.4M | $1.1B | ||
| Q2 24 | $328.6M | $1.0B | ||
| Q1 24 | $255.0M | $1.0B |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-2.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -0.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-2.9M | ||
| Q3 25 | $-18.9M | $8.2M | ||
| Q2 25 | $-21.0M | $-2.9M | ||
| Q1 25 | $-24.0M | $-7.4M | ||
| Q4 24 | $-24.5M | $1.3M | ||
| Q3 24 | $-21.0M | $13.7M | ||
| Q2 24 | $-25.5M | $-511.0K | ||
| Q1 24 | $-29.3M | $3.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | -0.35× | ||
| Q3 25 | — | 11.28× | ||
| Q2 25 | — | -17.24× | ||
| Q1 25 | — | -1.61× | ||
| Q4 24 | — | 12.13× | ||
| Q3 24 | — | 8.03× | ||
| Q2 24 | — | -0.34× | ||
| Q1 24 | — | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.